Research use only. All compounds are for use by qualified researchers in controlled laboratory environments — not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Compounds/SELANK
RESEARCH COMPOUND

SELANK

Synthetic Tuftsin Analogue

Developed by Russian Institute of Molecular Genetics. 40+ peer-reviewed preclinical studies. 3-lab independent COA on every batch.

Verified40+Peer-reviewed preclinical studies
VerifiedCOAPublished for every batch
Verified3Independent U.S. laboratories per batch
COAPublicEvery batch verifiable by batch number — free, no account.
01 / OVERVIEW

What is Selank?

Selank is a synthetic analogue of the immunomodulatory peptide Tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) that has been examined for anxiolytic-pathway signaling in models where sedation endpoints were not observed — a mechanism distinct from traditional anxiolytic compound classes.

With 40+ preclinical publications, Selank has been studied in models of BDNF (brain-derived neurotrophic factor) modulation, cognitive-endpoint testing, immune-pathway modulation, and anxiolytic-pathway signaling. In the same models, published work reports sedation and dependence endpoints unchanged relative to GABAergic comparators.

Selank is classified as a research-use-only compound. Research-grade material is not FDA approved for any use. All references below describe preclinical (in vitro or animal model) research contexts, not human clinical outcomes.
FDA STATUS: not FDA approved. Not FDA approved for any use. A pharmaceutical formulation is registered in the Russian Federation only; that registration has no standing in the United States.
02 / PRECLINICAL LITERATURE

Published preclinical research areas

01 / RESEARCH AREA

Anxiolytic signaling without sedation

Studied in preclinical models examining anxiety-related behavioural endpoints, with sedation endpoints reported as unchanged. Research explores modulation of GABA receptor expression and serotonergic pathway interactions without direct GABAergic agonism.

02 / RESEARCH AREA

BDNF modulation

Preclinical studies examine Selank's influence on brain-derived neurotrophic factor expression in hippocampal and cortical tissue models. Research explores neuroplasticity enhancement and neuroprotective signaling cascades.

03 / RESEARCH AREA

Cognitive-endpoint models

Research examines Selank's effects on memory consolidation, learning acquisition, and attention signaling in preclinical cognitive performance models. Studies explore both short-term and long-term memory pathway modulation.

04 / RESEARCH AREA

Immune pathway modulation

As a Tuftsin analogue, Selank has been examined for immunomodulatory activity — including cytokine expression modulation, NK cell activity, and immune response balancing in preclinical models without immunosuppression.

03 / FORMULATIONS

Available formulations at SMART MD

Selank 5mg
Lyophilized vial · Entry research quantity
Request info →
Selank 10mg
Lyophilized vial · Standard research quantity
Request info →
04 / VERIFICATION

SMART MD quality standard for Selank

  • HPLC purity analysis — identity and purity confirmed via high-performance liquid chromatography.
  • Mass spectrometry — molecular weight confirmation. Verifies correct peptide sequence.
  • LAL endotoxin assay — <5 EU/mg. Bacterial endotoxin safety verification.
  • 3 independent U.S. laboratories — rotating panel. No single lab relationship can compromise verification integrity.
  • Lot-specific COA — publicly verifiable at smartmdpeptides.com/verify before you reach out.
05 / RELATED

Related research compounds

Semax
ACTH analogue · Nootropic research
View →
DSIP
Delta sleep-inducing peptide · Sleep research
View →
PE-22-28
Spadin analogue · TREK-1 research
View →
06 / MORE INFORMATION

Questions about this compound?

A SMART rep can walk you through the formulations we document, the lot-specific COA for any batch, purity and endotoxin data, and storage and handling requirements for your protocol. Leave your name, email, phone, and what you're researching — a rep follows up within one business day. Research use only: we do not provide dosing, administration, or human-use guidance of any kind, and nothing we send is medical advice.

07 / FAQ

Selank FAQ

What Selank formulations does SMART MD document?+

Research-grade Selank with 3-lab COA verification is available at SMART MD Peptides in 5mg and 10mg formulations. Every batch is publicly verifiable at smartmdpeptides.com/verify.

What is the purity of SMART MD's Selank?+

Every Selank batch is third-party tested with a published COA. Each batch is independently verified by 3 U.S. laboratories — HPLC for purity, mass spectrometry for molecular weight, and LAL endotoxin assay for safety.

What makes Selank unique among nootropic peptides?+

Published preclinical work reports anxiolytic-pathway activity and cognitive-endpoint changes without the sedation or dependence endpoints recorded for GABAergic comparators in the same models. These are animal-model findings; no human conclusion follows from them. It also has immunomodulatory properties as a Tuftsin analogue.

Is Selank legal for research?+

Selank is legal to acquire for research purposes in the United States. It is classified as a research-use-only compound — not FDA-approved for therapeutic use, not intended for human consumption. Qualified researchers and research institutions may request documentation for preclinical laboratory research.

How should Selank be stored?+

Lyophilized (unreconstituted) Selank should be stored at -20°C, protected from light. Once reconstituted, store at 2-8°C and use within the timeframe specified on your lot-specific documentation.